Agenda

This panel will give the audience a current read on the marketplace for psychedelics. It is moderated by Shelby Hartman, the Co-Founder and CEO of Double-Blind Magazine a biannual print magazine... Read More

JR Rahn founder of MindMed will speak about the opportunities for micro-dosing and the opportunities for consumers who want the benefits of psychedelic drugs but without the lengthy time commitment.... Read More

Atai Life Sciences is a global biotech company that was created to address those suffering with mental health disorders. It has created a portfolio including Compass Pathways which uses Psilocybin... Read More

Lewis Goldberg, Managing Partner at Communications firm KCSA and Ronan Levy of Field Trip Ventures will talk about the similarities between the emerging psychedelic companies and the early days of... Read More

Network with company leaders and industry professionals. Sponsorship opportunities available.